Obesity Care
Information for healthcare professionals to learn more about the medical nutrition management of people living with obesity
Highlights of the month
- Scientific Publications
- External Links
Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies (2024)
The aim of this 2024 review was to provide the most contemporary evidence addressing changes in lean body mass and muscle composition with GLP-1-based therapies, along with current and developing mitigation strategies. The review focused on the complex relationship between muscle quantity, composition, function, and metabolic physiology, and the impacts of GLP-1-based treatments. It also addressed the challenges and opportunities in assessing and improving muscle health and sarcopenia during weight loss.
Neeland IJ, Linge J, Birkenfeld AL.Changes in lean body mass with glucagon-likepeptide-1-based therapies and mitigation strategies. DiabetesObes Metab. 2024;26(Suppl. 4):16‐27. doi:10.1111/dom.15728.
